Current prescription of DMARDs in patients receiving biologics and in the control groups
| DMARDs currently (%) | Etanercept | Infliximab | Anakinra | Control | |
|---|---|---|---|---|---|
| DMARD, disease modifying antirheumatic drug; NA, not assessed. | |||||
| No DMARD | 49.7 | 10.5 | 30.0 | NA | |
| Methotrexate alone | 32.7 | 63.8 | 60.0 | 20.2 | |
| Leflunomide alone | 7.8 | 13.4 | 5.7 | 20.0 | |
| Other single therapy | 3.3 | 1.7 | 1.4 | 4.7 | |
| Combination methotrexate + leflunomide | 1.8 | 3.8 | 1.4 | 23.5 | |
| Other combination of 2 DMARDs | 3.5 | 4.7 | 1.4 | 24.0 | |
| Combination of 3 DMARDs | 1.2 | 2.0 | 0.0 | 7.5 | |